Abstract
Data sources
Medline, EMbase and Cochrane databases
Study selection
Studies were included if they reported data on patients with a histologically-confirmed diagnosis of oral dysplasia. They also had to study at least one outcome measure and one intervention method or clinical risk factor. Outcome measures included malignant transformation rate (MTR) and time to malignant transformation (TMT). In studies on oral lesions, which contained a defined subset of patients with oral dysplasia, this subset but not all patients with oral lesions were included in the meta-analysis. Observational studies were included in the review due to the scarcity of randomised controlled trials with adequate follow-up period.
Data extraction and synthesis
Quality assessment was undertaken independently by two reviewers. When there was disagreement, a third reviewer was consulted. Quality criteria were agreed upon a priori, and the authors used a combination of quality assessment methods. Eligibility of studies was determined independently from the abstracts by two reviewers blinded to each other's selections. Outcome data were abstracted independently by a researcher and a statistician and checked by a third reviewer. Heterogeneity was assessed graphically in a forest plot and a meta-analysis was conducted. Subgroup analysis was performed by histologic grade, clinical risk factors and treatment modality.
Results
Fourteen non-randomised studies, reporting on 992 patients, were included. There was considerable heterogeneity between studies. The mean overall MTR was 12.1% (95% CI: 8.1%, 17.9%) and the mean TMT was 4.3 years. Histologic grade significantly affected mean MTR (p < 0.008). Furthermore, lesions that were not excised demonstrated considerably higher MTR than those that were excised (p = 0.003)
Conclusions
Oral dysplasia showed a significant rate of transformation to cancer, which was related to grade, and was decreased significantly but not eliminated by excision. Findings suggest the need for surgical excision and continued surveillance, particularly in high-grade lesions.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Jaber MA . Oral epithelial dysplasia in non-users of tobacco and alcohol: an analysis of clinicopathologic characteristics and treatment outcome. J Oral Sci. 2010; 52: 13–21.
Lan AX, Guan XB, Sun Z. [Analysis of risk factors for carcinogenesis of oral leukoplakia] in Chinese. Zhonghua Kou Qiang Yi Xue Za Zhi 2009; 44: 327–331.
Smith J, Rattay T, McConkey C, Helliwell T, Mehanna H . Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol. 2009; 45: 647–653.
Gouvêa AF, Vargas PA, Coletta RD, Jorge J, Lopes MA . Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia. J Oral Pathol Med. 2010; 39: 447–452.
Cao J, Liu HW, Jin JQ . [The effect of oral candida to development of oral leukoplakia into cancer] in Chinese. Zhonghua Yu Fang Yi Xue Za Zhi 2007; 41 Suppl: 90–93.
Huff KD, Garren KC, Huff MS . A novel, minimally invasive approach to managing mild epithelial dysplasia. Gen Dent. 2010; 58: 126–129.
Author information
Authors and Affiliations
Additional information
Address for Correspondence: Hisham M. Mehanna, Department of Head and Neck Surgery, Institute of Head and Neck Studies and Education, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom. E-mail: hisham.mehanna@uhcw.nhs.uk
Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck 2009; 31: 1600–1609
Rights and permissions
About this article
Cite this article
Al-Dakkak, I. Oral dysplasia and risk of progression to cancer. Evid Based Dent 11, 91–92 (2010). https://doi.org/10.1038/sj.ebd.6400745
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.ebd.6400745
